Biogen Test Finds Tysabri Patients With 1% Risk of Getting Brain Disease
By Michelle Fay Cortez – Apr 15, 2011 Biogen Idec Inc. (BIIB) has identified high-risk patients taking its multiple sclerosis drug Tysabri who have…
Tysabri Label Modified to Include More Brain Infection Data
April 8, 2011 Tysabri, the multiple sclerosis drug marketed by Biogen Idec Inc. and Elan Corp is having its label updated…
Stuart Schlossman
Neurologists Anticipate Increased Use of Novartis’ Gilenya and Biogen Idec’s Tysabri over the Next Six Months Despite Safety Concerns Surrounding Both Products
March 30, 2011 EXTON, Pa.–(BUSINESS WIRE)–Physician trial and market share of Novartis’ Gilenya, the first oral disease modifying agent (DMA)…
Stuart Schlossman
Tysabri reports 10 more brain disease cases
By Geoff Percival Saturday, February 19, 2011 THE owners of multiple sclerosis drug Tysabri have reported a further 10 cases of the rare brain…
Stuart Schlossman
Tysabri Vs. Novantrone. Which is right for you?
Some people can’t or don’t want to take the CRAB drugs. For some, there is Tysabri. Others are excited about…
Stuart Schlossman
European Neurologists Expect Significant Increases In The Use Of Both Tysabri And Extavia In Their Multiple Sclerosis Patients
December 28, 2010 BioTrends Research Group, Inc. finds that while neurologists in the EU tend to prescribe the established interferon…
Stuart Schlossman
DATA FURTHER SUPPORTING ANTI-JC VIRUS ANTIBODY ASSAY PRESENTED AT THE 26TH CONGRESS OF THE European Committee for Treatment and Research in Multiple Sclerosis
– Studies support potential of assay to stratify risk of PML in TYSABRI-treated patients – Gothenburg, Sweden – October 16, 2010…
Stuart Schlossman
New Test Assessing PML Risk With Natalizumab Targeted for Early 2011
Medscape Medical News Allison Gandey Authors and Disclosures October 18, 2010 (Gothenburg, Sweden) — A new assay measuring JC virus…
Stuart Schlossman
Researchers from Biogen Idec Inc and Elan Corporation Inc say they have developed an enzyme-linked immunosorbent assay (ELISA) that can detect JC virus (JCV) antibodies
Anti-JCV Antibody ELISA Could Help Determine PML Risk Megan Brooks – Authors and Disclosures August 27, 2010 — Researchers from Biogen…
Stuart Schlossman
Clearing some of the Confusion on: Natalizumab (Tysabri)
Cherie Binns commented on your note “Cladribine and Natalizumab can adversely interact”. Cherie wrote: “I’d like to clear some confusion.…
Stuart Schlossman
